CRM · NYSE
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $41.52B | $37.90B | $34.86B | $31.35B | $26.49B | $21.25B | $17.10B | $13.28B |
| Cost of Revenue | $9.27B | $8.64B | $8.54B | $8.36B | $7.03B | $5.44B | $4.24B | $3.45B |
| Gross Profit | $32.26B | $29.25B | $26.32B | $22.99B | $19.47B | $15.81B | $12.86B | $9.83B |
| Research & Development | $5.99B | $5.49B | $4.91B | $5.05B | $4.46B | $3.60B | $2.77B | $1.89B |
| Selling, General & Administrative | $3.00B | $2.84B | $2.53B | $2.55B | $2.60B | $2.09B | $1.70B | $1.35B |
| Operating Expenses | $23.92B | $22.05B | $21.30B | $21.96B | $18.92B | $15.36B | $12.57B | $9.30B |
| Operating Income | $8.33B | $7.21B | $5.01B | $1.03B | $548.00M | $455.00M | $297.00M | $535.00M |
| Interest Expense | $324.00M | $272.00M | $283.00M | $300.00M | $216.00M | $110.00M | $110.00M | $154.00M |
| Other Income / (Expense) | $172.00M | $354.00M | $216.00M | -$131.00M | -$227.00M | — | -$18.00M | -$94.00M |
| Income Before Taxes | $9.52B | $7.44B | $4.95B | $660.00M | $1.53B | $2.56B | $706.00M | $983.00M |
| Provision for Income Taxes | $2.06B | $1.24B | $814.00M | $452.00M | $88.00M | -$1.51B | $580.00M | -$127.00M |
| Net Income | $7.46B | $6.20B | $4.14B | $208.00M | $1.44B | $4.07B | $126.00M | $1.11B |
| Basic EPS | $7.85 | $6.44 | $4.25 | $0.21 | $1.51 | $4.48 | $0.15 | $1.48 |
| Diluted EPS | $7.80 | $6.36 | $4.20 | $0.21 | $1.48 | $4.38 | $0.15 | $1.43 |
| Basic Shares Outstanding | 950.00M | 962.00M | 974.00M | 992.00M | 955.00M | 908.00M | 829.00M | 751.00M |
| Diluted Shares Outstanding | 956.00M | 974.00M | 984.00M | 997.00M | 974.00M | 930.00M | 850.00M | 775.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jan 2027 | $10.27 | $9.95 | $11.35 | 19 | ↑0 ↓0 |
| Jan 2028 | $11.01 | $9.82 | $12.41 | 16 | ↑1 ↓2 |
| Jan 2029 | $13.47 | $13.30 | $13.63 | 2 | ↑1 ↓0 |